<?xml version="1.0" encoding="UTF-8"?>
<definitions 
xmlns="http://www.omg.org/spec/BPMN/20100524/MODEL" 
xmlns:bpmndi="http://www.omg.org/spec/BPMN/20100524/DI" 
xmlns:omgdc="http://www.omg.org/spec/DD/20100524/DC" 
xmlns:omgdi="http://www.omg.org/spec/DD/20100524/DI" 
xmlns:signavio="http://www.signavio.com" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" exporter="Signavio Process Editor, http://www.signavio.com" exporterVersion="6.4.0" expressionLanguage="http://www.w3.org/1999/XPath" id="sid-3f3d8f40-3827-42bd-9a88-f1ea762c2c62" targetNamespace="http://www.signavio.com/bpmn20" typeLanguage="http://www.w3.org/2001/XMLSchema" xsi:schemaLocation="http://www.omg.org/spec/BPMN/20100524/MODEL http://www.omg.org/spec/BPMN/2.0/20100501/BPMN20.xsd">




<conditionExpression id="sid-04894d52-d1d9-4413-be47-01d612a9e84c" xsi:type="tFormalExpression">For patients who have 1 of the following less well-validated risk factors (age 65 to 74 y, female gender, or CAD) </conditionExpression>

<conditionExpression id="sid-5023436a-4626-4cc2-b79e-27d5dad70e70" xsi:type="tFormalExpression">patient needs stroke prevention AND patient refuses OAC AND patient cannot tolerate aspirin-clopidogrel combination therapy</conditionExpression>

<conditionExpression id="sid-385f8c4b-174b-4f6b-a709-5fe4a8741505" xsi:type="tFormalExpression">patient &lt; 65 years and lone AF (including females)</conditionExpression>

<conditionExpression id="sid-706ce6cf-4f94-4a64-bef9-181cad6e4048" xsi:type="tFormalExpression">age &lt; 65 and lone AF</conditionExpression>

<conditionExpression id="sid-65a7e5ba-de09-4415-9890-c6c86d51f1f8" xsi:type="tFormalExpression">non-valvular AF AND (previous stroke OR TIA OR systemic embolism OR LVEF (left ventricular ejection fraction) &lt; 40% AND symptomatic heart failure AND (age &gt;= 75 OR (age &gt;=65 AND (diabetes OR coronary artery disease OR hypertension))))</conditionExpression>




<conditionExpression id="sid-04894d52-d1d9-4413-be47-01d612a9e11c" xsi:type="tFormalExpression">recurrent (paroxymal or persistent) AF AND after cardioversion AND (high risk for drug-induced adverse effects OR high risk with infrequent recurrences of AF)</conditionExpression>

<conditionExpression id="sid-04894d52-d1d9-4413-be47-01d612a9e12c" xsi:type="tFormalExpression">for patients with (persistent or permanent) AF</conditionExpression>

<conditionExpression id="sid-04894d52-d1d9-4413-be47-01d612a9e13c" xsi:type="tFormalExpression">in the absence of preexcitation</conditionExpression>

<conditionExpression id="sid-04894d52-d1d9-4413-be47-01d612a9e14c" xsi:type="tFormalExpression">in patients with AF and HF who do not have an accessory pathway</conditionExpression>

<conditionExpression id="sid-04894d52-d1d9-4413-be47-01d612a9e15c" xsi:type="tFormalExpression">In patients who experience symptoms related to AF during activity</conditionExpression>


</definitions>